Just another MAO-B inhibitor with no proven advantages

首页> 外文期刊>Prescrire international >Just another MAO-B inhibitor with no proven advantages

【24h】

Just another MAO-B inhibitor with no proven advantages

机译：只是另一个Mao-B抑制剂，没有经过验证的优势

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Patients with Parkinson's disease frequently develop motor disorders, including motor fluctuations, after several years on levodopa. In this situation, when optimisation of levodopa therapy is inadequate, adding an oral non-ergot derived dopamine agonist such as ropinirole is the option with the best harm-benefit balance. The addition of a monoamine oxidase B (MAO-B) inhibitor should be discussed on a case-by-case basis, but the harm-benefit balance of these drugs is most often unfavourable.

机译：帕金森病患者在服用左旋多巴几年后经常出现运动障碍，包括运动波动。在这种情况下，当左旋多巴疗法的优化不够充分时，添加口服非麦角衍生多巴胺激动剂（如罗哌尼罗）是一种具有最佳利弊平衡的选择。添加单胺氧化酶B（MAO-B）抑制剂应根据具体情况进行讨论，但这些药物的利弊平衡通常是不利的。

著录项

来源
《Prescrire international》 |2017年第184期|共3页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. Monoamine oxidase-B (MAO-B) inhibitors: implications for disease-modification in Parkinson’s disease [J] . Kay Cheong Teo, Shu-Leong Ho 转化神经变性病(英文) . 2013,第001期
2. Screening for MAO-A and MAO-B inhibitors by highthroughput screening methods [J] . Hong-meiGUANG, Guan-huaDU 中国药理学报：英文版 . 2004,第011期
3. Novel strategy of constructing fluorescent probe for MAO-B via cascade reaction and its application in imaging MAO-B in human astrocyte [J] . Huihuan Qin, Lingling Li, Kun Li, 中国化学快报（英文版） . 2019,第001期
4. Just another MAO-B inhibitor with no proven advantages [J] . Prescrire international . 2017,第184期

机译：只是另一个Mao-B抑制剂，没有经过验证的优势
5. A third factor Xa inhibitor anticoagulant: no proven advantages [J] . Prescrire international . 2017,第178期

机译：第三个因素XA抑制剂抗凝血剂：没有经过验证的优势
6. Development of potential selective and reversible pyrazoline based MAO-B inhibitors as MAO-B PET tracer precursors and reference substances for the early detection of Alzheimer's disease [J] . Neudorfer Catharina, Shanab Karem, Jurik Andreas, Bioorganic and Medicinal Chemistry Letters . 2014,第18期

机译：开发潜在的选择性和可逆吡唑啉基MAO-B抑制剂作为MAO-B PET示踪剂前体和参考物质，用于早期发现阿尔茨海默氏病
7. Understanding Insulation Chemistry Proven to Inhibit Corrosion Under Insulation (CUI) [C] . David Shong Corrosion conference and expo . 2017

机译：了解被证明可以抑制绝缘腐蚀的绝缘化学（CUI）
8. The Treatment of Parkinson's Disease Using Novel MAO-B Inhibitors. [D] . Parsons, Austin Joseph. 2017

机译：使用新型MAO-B抑制剂治疗帕金森氏病。
9. Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer’s disease [O] . Jong-Hyun Park, Yeon Ha Ju, Ji Won Choi, 2019

机译：新开发的可逆MAO-B抑制剂规避了不可逆抑制剂在阿尔茨海默氏病中的缺点
10. Combined treatment with MAO-A inhibitor and MAO-B inhibitor increases extracellular noradrenaline levels more than MAO-A inhibitor alone through increases in β-phenylethylamine [O] . Kitaichi, Yuji, Inoue, Takeshi, Nakagawa, Shin, 2010

机译：与MAO-A抑制剂和MAO-B抑制剂联合治疗可通过增加β-苯乙胺使细胞外去甲肾上腺素水平比单独的MAO-A抑制剂高
11. Medicare Demonstration PPOs: Financial and Other Advantages for Plans, Few Advantages for Beneficiaries;Report to the Congress [R] . 2004

机译：医疗保险示范ppO：计划的财务和其他优势，受益人的优势很少;向国会报告

Just another MAO-B inhibitor with no proven advantages

摘要

著录项

相似文献

相关主题

期刊订阅